Julie M. King, PharmD

Case Report and Brief Review

Tetrabenazine Treatment for Post-Stroke Choreiform Movements

12/23/2019

Jonathan T. Stewart , MD, DLFAPA, AGSF, DFAPA;

Movement disorders after stroke are unusual, seen in between 1% and 4% of patients, but can significantly worsen disability. We report a patient whose disabling post-stroke hemichorea responded well to tetrabenazine, a selective vesicular...

Movement disorders after stroke...

12/23/2019

Annals of Long-Term Care

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 6 ⁠–⁠ November 8

November 7 ⁠–⁠ November 10

November 8

November 8 ⁠–⁠ November 10

November 13 ⁠–⁠ November 16

November 14 ⁠–⁠ November 15

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

See Full Calendar

Julie M. King, PharmD

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products